Gail Mannix »

Intellia Therapeutics shares owned by Gail Mannix

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Gail Mannix from 13F filings

Historical chart of Gail Mannix investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Gail Mannix consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Gail Mannix

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.0M 256k 27.51

More positions owned by Gail Mannix

Apple (AAPL)
Johnson & Johnson (JNJ)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Small Cp Etf (VB)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Lam Research Corporation (LRCX)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Xylem (XYL)
Regeneron Pharmaceuticals (REGN)

View all positions for Gail Mannix

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Wellington Management Company
FMR
Geode Capital Management
Federated Investors
T. Rowe Price Associates
Alliancebernstein
Citadel Advisors
Rokos Capital Management
Casdin Capital
Contrarius Investment Management

View all funds holding Intellia Therapeutics